Coherus Biosciences | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amarin USD 45.66M 5.3M 2025-03
Amgen USD 2.41B 498M 2025-03
Baxter International USD 968M 127M 2024-12
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Fujifilm JPY 281.03B 5.7B 2025-03
Gilead Sciences USD 833M 70M 2024-12
Ironwood Pharmaceuticals USD 2.13M 1.11M 2024-12
Merck USD 3.78B 295M 2025-03
Myriad Genetics USD 28.1M 4.2M 2025-03
Pacira USD 23.17M 4.04M 2025-03
Perrigo USD 502.3M 7.1M 2025-03
Pfizer USD 5.24B 393M 2025-03
PTC Therapeutics USD 15.15M 2.12M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
Teva Pharmaceutical Industries USD 2.29B 87M 2025-03
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Xencor USD 16.19M 568K 2025-03
Zoetis USD 420M 13M 2025-03


Coherus Biosciences Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.